Merit Medical Shareholders Elect Silvia M. Perez as New Director

Yahoo Finance15:05

3M's executive annual compensation plan was not supported by shareholders

Glonghui, May 15 | 3M said on Tuesday that the annual compensation plans of some executives, including former CEO Mike Roman, did not receive the necessary number of shareholders' approval. Roman's total compensation for 2023 was $16.4 million, while total compensation for 2022 was around $14 million, although the company is still dealing with the impact of multiple lawsuits and slowing sales. The company said in a statement that although the vote is not binding, the company's board of directors (including the Remuneration and Talent Committee) sees the results of the shareholders' meeting as one of the key inputs in the remuneration review process. ex

Gelonghui FinanceMay 14 21:14

3M Raised to Buy From Hold by Vertical Research

3M Raised to Buy From Hold by Vertical Research

Dow Jones14:04

3M Price Target Raised to $140.00/Share From $92.00 by Vertical Research

3M Price Target Raised to $140.00/Share From $92.00 by Vertical Research

Dow Jones14:04

Vertical Research: The 3M (MMM.US) rating was raised, adjusted from holding to buying, and the target price was adjusted from $92.00 to $140.00.

Vertical Research: The 3M (MMM.US) rating was raised, adjusted from holding to buying, and the target price was adjusted from $92.00 to $140.00.

Zhitong Finance14:02

Vertical Research Upgrades 3M to Buy, Raises Price Target to $140

Vertical Research analyst Jeffrey Sprague upgrades 3M from Hold to Buy and raises the price target from $92 to $140.

Analyst Upgrades13:53